rxstat › Drug prices › Ritonavir

Ritonavir (Norvir) price in Canada

Partial shortage

Source: Health Canada shortage reports · Updated Oct 27, 2026

Ritonavir 100 mg tablet costs about $1.17 to $1.55 per tablet on public drug plan price lists across 4 provinces, before the pharmacy's dispensing fee. The brand (Norvir) lists at $1.66.

Some Ritonavir products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 15, 2026.

Price by province

Strength and formABSKONNBNSNL
100 mg Tabletper tablet$1.34not covered$1.17brand $1.55$1.17brand $1.57$1.55–$1.28brand $1.66
Plan coverageNot coveredSpecial approvalCoveredCoveredNot coveredPrice list

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay. In Ontario, the plan pays only up to the lowest interchangeable price ($1.17 per tablet for 100 mg).

Listed products by province

Alberta: 2 products
  • Auro-Ritonavir 100 mg Tablet · AUR
    DIN 02523620 · $1.34/tablet · Not covered
  • Norvir 100 mg Tablet · ABV
    DIN 02357593 · $1.55/tablet · Not covered
Saskatchewan: 2 products
  • Auro-Ritonavir 100 mg Tablet · API
    DIN 02523620 · $1.17/tablet · Special approval
  • Norvir 100 mg Tablet · ABV
    DIN 02357593 · $1.55/tablet · Special approval
Ontario: 2 products
  • Auro-Ritonavir 100 mg Tablet · Auro Pharma Inc.
    DIN 02523620 · $1.17/tablet · Covered
  • Norvir 100 mg Tablet · Abbott Laboratories Limited
    DIN 02357593 · $1.57/tablet · Covered
New Brunswick: 1 product
  • Norvir 100 mg Tablet · ABV
    DIN 02357593 · $1.55/tablet · Covered
Nova Scotia: 1 product
  • Norvir 100 mg Tablet · ABV
    DIN 02357593 · no listed price · Not covered
Newfoundland and Labrador: 2 products
  • Auro-Ritonavir 100 mg Tablet · AUR
    DIN 02523620 · $1.28/tablet · Price list
  • Norvir 100 mg Tablet · ABV
    DIN 02357593 · $1.66/tablet · Price list

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026) · Newfoundland and Labrador Interchangeable Drug Products Formulary (Oct 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
1 / 3
In shortage since
Oct 26, 2026
Est. full return
Dec 15, 2026
Reports on file
4
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
AURO-RITONAVIR
100MG · TABLET · AURO PHARMA INC
DIN 02523620 · since Oct 26, 2026, est. end Dec 15, 2026 · Delay in Shipping
To be discontinued
NORVIR
100MG · TABLET · ABBVIE CORPORATION
DIN 02357593
Resolved
AURO-RITONAVIR
100MG · TABLET · AURO PHARMA INC
DIN 02523620 · ended Nov 15, 2024 · Demand increase for the drug.
Discontinued
NORVIR
80MG · SOLUTION · ABBVIE CORPORATION
DIN 02229145

What's happening

Ritonavir is currently affected by an active shortage report filed with Health Canada by AURO PHARMA INC.

The reported cause is: delay in shipping. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Ritonavir is classified under “DIRECT ACTING ANTIVIRALS” (ATC J05AE).

Recent changes

Common questions

How much does Ritonavir cost in Canada?

Ritonavir 100 mg tablet costs about $1.17 to $1.55 per tablet on public drug plan price lists across 4 provinces, before the pharmacy's dispensing fee. The brand (Norvir) lists at $1.66.

Is Ritonavir covered by provincial drug plans?

On the public plans' own lists: Alberta: not covered; Saskatchewan: special approval; Ontario: covered; New Brunswick: covered; Nova Scotia: not covered; Newfoundland and Labrador: price list. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Ritonavir be back in stock in Canada?

The latest manufacturer estimate is Dec 15, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Ritonavir in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (direct acting antivirals)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.